University of Iowa
Iowa City, Iowa, 52242, United States
Location status: Recruiting
NCT Number: NCT06974357
Kidney stones continue to affect more and more people in the United States with the most recent estimate being 1 in 9 people will develop a stone in their life. While family history is a known risk factor for stone disease, it remains unclear whether this is related to learned dietary habits or a truly inheritable genetic condition. Known inheritable genetic conditions linked to stone formation are uncommon, and thus, routine genetic testing is not currently recommended by any major urologic organizations. Patients who form calcium phosphate predominant stones, a less common type of stone composition, tend to have alkaline urine pH which suggests that the kidneys are unable to rid the body of acid. Management of such patients for stone prevention can be difficult. The Iowa Institute for Human Genomics is one of only a handful of commercial labs which offers genetic testing for stone disease. The aim of this study is to assess the rate of genetic abnormalities amongst calcium phosphate predominant stone formers with alkaline urine. To this end, the investigators plan to enroll calcium phosphate predominant stone forming patients with alkaline urine on 24 hour urine collection who obtain their health care at UIHC to undergo free genetic testing via blood draw to assess for genetic abnormalities. The investigators will also collect information already available in the subject's chart to assess for other patterns between blood and urine tests and any genetic variants.
Interested in participating?
Request Info18 year–90 year
All sexes
Interventional
Not applicable
Iowa City, Iowa, 52242, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
blood draws for genetic testing
Time frame: 1 year
assess the overall rate of genetic variants among the stone population
Contact information is provided by the study sponsor or research team.
Ryan L Steinberg
Other
Evaluation of Genetic Abnormalities Amongst Calcium Phosphate Predominant Stone Formers With Alkaline Urine pH on 24 Hour Urine Testing
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06989320
Calculi, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT06330246
Calculi, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT06331546
Calculi, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT07072598
Calculi, Female Urogenital Diseases
Chicago, Illinois, United States
View Trial Details